CAREMINDr is a healthcare technology company specializing in mobile-enabled remote patient monitoring (mRPM) and chronic care management solutions. Its platform leverages AI and continuous patient-generated health data to help healthcare providers monitor and manage chronic conditions such as hypertension, diabetes, pregnancy, and mental health remotely. CAREMINDr primarily serves healthcare providers, Federally Qualified Health Centers, employers, insurers, and third-party administrators by enabling real-time health data capture, automated alerts, and personalized interventions that improve patient outcomes and sustain medical practice revenues. The company’s solutions include the CAREMINDr.AI product suite with modules like Awareness, Journey, and Journey+ that offer scalable, secure, and integrated chronic care management with device connectivity and billing automation[1][2][3].
Founded in 2017 (or 2018, with some sources citing 2018) in Silicon Valley, CAREMINDr was created by founders with extensive experience across health insurance, practice management, wellness, health systems, and population health. The idea emerged from recognizing the limitations of episodic healthcare visits and the potential of continuous patient data capture enabled by smartphones, biometric scanning, cloud infrastructure, and AI. This convergence allowed CAREMINDr to pioneer a “healthcare umbilical cord” concept—continuous real-time connection between patients and care teams to enable timely interventions that reduce costs and save lives. Early traction included launching remote patient monitoring solutions during the COVID-19 pandemic and securing partnerships with healthcare providers and Federally Qualified Health Centers[1][4][5].
CAREMINDr rides the growing trend of digital health transformation and telehealth expansion, accelerated by the COVID-19 pandemic and increasing demand for remote chronic care management. The timing is critical as healthcare shifts from reactive episodic care to proactive, continuous population health management supported by AI and connected devices. Market forces such as rising chronic disease prevalence, healthcare cost pressures, and regulatory support for remote patient monitoring (e.g., CMS reimbursement for Chronic Care Management) favor CAREMINDr’s solutions. By enabling real-time patient monitoring and data-driven interventions, CAREMINDr influences the broader ecosystem by helping providers improve outcomes, reduce costs, and adapt to value-based care models[1][3][5].
CAREMINDr is positioned to expand its impact by enhancing device integration (e.g., upcoming A1C scanning), broadening condition coverage, and deepening AI capabilities for predictive analytics. Trends shaping its journey include increased adoption of digital health tools, employer-driven wellness programs, and payer incentives for chronic care management. As healthcare continues to embrace continuous monitoring and AI-driven insights, CAREMINDr’s “healthcare umbilical cord” concept could become a standard for chronic condition management, potentially scaling across diverse healthcare settings and populations. Its influence may grow by enabling more personalized, efficient, and data-rich care pathways that align with evolving healthcare reimbursement and quality frameworks[2][3][4].
Caremindr has raised $100K in total across 1 funding round.
Caremindr's investors include Monkey Byte Development, Inc..
Caremindr has raised $100K across 1 funding round. Most recently, it raised $100K Seed in December 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 1, 2022 | $100K Seed | Monkey Byte Development, Inc. |